{"changeSha256":"58cbfa4fc7452aaadca50e26099c7004d72efc561126518237a889f1fb5c908b","changedAt":"2026-11-16","changedFields":[{"after":"Development of chondroitin sulfate‑stabilized PLGA microspheres of exenatide via polarity gradient extraction.","before":"Development of Chondroitin Sulfate ‑ Stabilized PLGA Microspheres of Exenatide via Polarity Gradient Extraction.","field":"Headline"},{"after":"PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","before":"PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","field":"Summary"},{"after":"2026-10-30","before":"2026-09-08","field":"Cited source date"},{"after":"2026-11-16","before":"2026-09-09","field":"Source observed date"},{"after":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e-r2","before":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e","field":"Cited source records"},{"after":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e-r2","before":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e","field":"Headline citations"},{"after":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e-r2","before":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e","field":"Summary citations"},{"after":"1. PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. [sources: pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e-r2]\n2. This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. [sources: pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e-r2]","before":"1. PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. [sources: pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e]\n2. This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. [sources: pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e]","field":"Attributable context"},{"after":"2d08bd01be3ecfa5274b4177f1b26c9df6241bdc2d9275560ce32844bffa91fe","before":"5d05432049102feefa6ebeed4c8e4240ac757e1de40a7546110e89d12388d552","field":"Source snapshot commitment"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/stories/pubmed-pmid-42709517-exenatide/#version-2","version":2},"id":"story:pubmed-pmid-42709517-exenatide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"record-updated","notice":"PubMed revised the bibliographic metadata of PMID 42709517, with a metadata revision date of 2026-10-30. This version reports that observation; the earlier retained observation remains available as version 1.","peptideSlugs":["exenatide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/stories/pubmed-pmid-42709517-exenatide/#version-1","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"pubmed-observation-pmid-42709517-2026-09-08-8c8d68644f0e-r2","name":"PubMed","sourceClass":"A","title":"Development of chondroitin sulfate‑stabilized PLGA microspheres of exenatide via polarity gradient extraction. · retained source version 1:2026-10-30:current:62a63971814bb423fbc37e1b457f5a356652b2fccf219a3ee6390cdcbbab4d60","url":"https://pubmed.ncbi.nlm.nih.gov/42709517/","verifiedAt":"2026-11-16"}],"subject":{"slug":"pubmed-pmid-42709517-exenatide","type":"story"}}
